Research Explores Neurocognitive Profile, Cognitive Impairment in MDD
A literature review provided new insight into the clinical neurocognitive profile in major depressive disorder (MDD) and its relationship to cognitive deficits.
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation
Potentiating current antidepressant treatment is much needed. Based on animal studies, caffeine may augment the effects of currently available antidepressants.
Personalizing rTMS Parameters For Depression Treatment Using Multimodal Neuroimaging
Repetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment to neuropsychiatric disorders such as major depressive disorder (MDD).
Neuromodulation Therapy May Improve Treatment-Resistant Depression
A high dose of intermittent theta-burst stimulation with functional-connectivity-guided targeting outperformed sham stimulation for treatment-resistant depression.
Left Dorsolateral Prefrontal Cortex rTMS in Alleviating MTBI Related Headaches and Depressive Symptoms
Persistent mild traumatic brain injury related headache (MTBI-HA) represents a neuropathic pain state.
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression
Antidepressant outcomes to repetitive transcranial magnetic stimulation (rTMS) are better when stimulation is serendipitously delivered to the prefrontal cortex.
Treatment Resistant Depression: Case Report
rTMS treatment for Major Depressive Disorder MDD involves stimulation of the dorsolateral prefrontal cortex which plays an important role in cognitive function and mood.
Study Uses Non-invasive Technique To Help Veterans With Depression, Concussion
Promising studies using repetitive T to help veterans and active-duty service members living with depression, post-traumatic stress disorder (PTSD), and other lasting consequences of concussion.
Pilot Study: New Approach to Help Adults with Autism and Depression
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.